Os06g0519400 Antibody

What is Os06g0699400 and what are its common synonyms in scientific literature?

Os06g0699400 is a gene that encodes Mitogen-activated protein kinase 4 in rice (Oryza sativa). The protein is commonly known by several synonyms in scientific literature, including OsMPK4, OsMAPK4, and OsMSRMK3. Additionally, it may be referred to as MAP kinase 2 (Os06t0699400-01) in some databases and publications . These multiple designations reflect the protein's characterization across different research contexts and experimental systems. When searching literature or designing experiments, researchers should include all synonyms to ensure comprehensive coverage of relevant studies.

What is the structural and functional significance of Os06g0699400/OsMPK4 in plant systems?

Os06g0699400/OsMPK4 functions as a mitogen-activated protein kinase that plays critical roles in cellular signaling cascades. As a member of the MAPK family, it participates in phosphorylation cascades that transduce extracellular signals to cellular responses. In plants, MPK4 proteins are implicated in multiple physiological processes including stress responses, defense mechanisms, and developmental regulation. Specifically, OsMPK4 is involved in signaling pathways that respond to both biotic stressors (pathogens) and abiotic stressors (environmental factors such as drought, salinity, and temperature fluctuations). The protein contains characteristic MAPK domains including the catalytic kinase domain and regulatory regions that control its activation state through phosphorylation events . Understanding these structural and functional characteristics is essential for designing experiments that properly analyze OsMPK4's role in specific signaling pathways.

What cross-reactivity profile does Os06g0699400 antibody demonstrate across plant species?

The Os06g0699400 antibody demonstrates extensive cross-reactivity across multiple plant species, making it a versatile tool for comparative studies across different model systems. Based on specificity testing, the antibody (PHY4104S) shows reactivity with proteins from numerous species including:

This extensive cross-reactivity is particularly noteworthy as it suggests high conservation of the epitope recognized by the antibody across diverse plant lineages . Researchers should validate the specificity in their particular species of interest through appropriate controls before proceeding with experimental applications.

What are the optimal storage and handling conditions for maintaining Os06g0699400 antibody activity?

The Os06g0699400 antibody is typically provided in lyophilized form to maximize stability during shipping and long-term storage. For optimal maintenance of antibody activity, researchers should follow these evidence-based protocols:

• Storage conditions: Store the lyophilized antibody at -20°C in a manual defrost freezer. After reconstitution, aliquot to avoid repeated freeze-thaw cycles, which significantly reduce antibody activity.

• Shipping considerations: The product is shipped at 4°C, but upon receipt, it should immediately be transferred to the recommended storage temperature.

• Reconstitution protocol: Reconstitute using sterile distilled water or an appropriate buffer at neutral pH. Allow the lyophilized product to reach room temperature before reconstitution to prevent condensation that could affect protein stability.

• Working dilutions: Prepare working dilutions fresh on the day of use. Working dilutions should be stored at 4°C and used within 24 hours .

These handling procedures are critical for maintaining epitope recognition capability and preventing protein degradation that could lead to false negative results or increased background in experimental applications.

How can researchers validate the specificity of Os06g0699400 antibody in experimental systems?

Validating antibody specificity is crucial for ensuring experimental rigor. For Os06g0699400 antibody, a comprehensive validation approach should include:

• Western blot analysis with positive and negative controls:

  • Positive control: Protein extracts from rice (Oryza sativa) tissues known to express OsMPK4

  • Negative control: Protein extracts from tissues or organisms lacking the target protein or from knockdown/knockout lines

• Peptide competition assay: Pre-incubate the antibody with the immunizing peptide before application in Western blot or immunostaining. Signal elimination confirms specificity.

• Cross-reactivity assessment: Test the antibody against related MPK family members, particularly OsMPK3, which shares sequence homology. Note that the sequence of the synthetic peptide used for PHY4570S antibody production is 100% homologous with the sequence in OsMPK3 (Os02g0148100) .

• Immunoprecipitation followed by mass spectrometry: This approach provides definitive identification of proteins recognized by the antibody.

• Signal correlation with gene expression: Correlation between protein detection levels and known transcript levels across tissues provides supporting evidence for specificity.

Implementing these validation steps ensures that experimental findings accurately reflect Os06g0699400/OsMPK4 biology rather than artifacts from non-specific antibody binding.

What methodological approaches can enhance the detection sensitivity of Os06g0699400 in low-abundance samples?

When working with low-abundance samples, several methodological enhancements can significantly improve detection sensitivity:

• Signal amplification systems:

  • Implement tyramide signal amplification (TSA) for immunohistochemistry

  • Use high-sensitivity chemiluminescence substrates for Western blots

  • Consider quantum dot conjugates for fluorescence applications

• Sample preparation optimization:

  • Employ phosphatase inhibitors to preserve phosphorylated forms of OsMPK4

  • Use specialized extraction buffers designed for membrane-associated proteins

  • Implement subcellular fractionation to concentrate the target protein

• Enrichment techniques:

  • Perform immunoprecipitation before Western blotting

  • Use affinity purification to concentrate the target protein

  • Consider proximity ligation assays (PLA) for in situ protein interaction studies

• Detection optimization:

  • Extend primary antibody incubation time (overnight at 4°C)

  • Optimize blocking conditions to reduce background while preserving specific signals

  • Use monovalent antibody fragments to improve tissue penetration in immunohistochemistry

These methodological enhancements should be systematically optimized for the specific experimental context, as their effectiveness may vary depending on tissue type, fixation methods, and the specific research question being addressed .

How can Os06g0699400 antibody be utilized to investigate MAPK signaling cascades in response to biotic and abiotic stresses?

Os06g0699400 antibody provides a powerful tool for dissecting MAPK signaling cascades in response to various stressors. Methodological approaches include:

• Phosphorylation-specific analysis:

  • Use phospho-specific antibodies in combination with Os06g0699400 antibody to track activation states

  • Implement Phos-tag™ SDS-PAGE to resolve phosphorylated from non-phosphorylated forms

  • Compare total OsMPK4 levels (using Os06g0699400 antibody) with activated forms (using phospho-specific antibodies)

• Temporal signaling dynamics:

  • Design time-course experiments to capture rapid activation events (minutes to hours)

  • Implement pulse-chase approaches to determine protein turnover rates during stress responses

  • Use pharmacological inhibitors of upstream kinases to dissect pathway dependencies

• Spatial signaling analysis:

  • Perform subcellular fractionation coupled with immunoblotting to track OsMPK4 translocation

  • Use immunofluorescence microscopy to visualize OsMPK4 localization changes during stress responses

  • Implement tissue-specific extraction to compare signaling dynamics across different plant organs

• Interactome analysis:

  • Perform co-immunoprecipitation with Os06g0699400 antibody followed by mass spectrometry

  • Use proximity-dependent labeling approaches (BioID, APEX) to identify transient interaction partners

  • Implement yeast two-hybrid screens using OsMPK4 as bait and validate interactions with co-IP using the antibody

These methodological approaches enable researchers to build comprehensive models of how OsMPK4 functions within larger signaling networks that orchestrate stress responses in plants .

What are the key considerations for designing immunoprecipitation experiments with Os06g0699400 antibody?

Successful immunoprecipitation (IP) experiments with Os06g0699400 antibody require careful optimization of several parameters:

• Lysis buffer optimization:

  • Use non-denaturing buffers that preserve protein-protein interactions (typically Tris or HEPES-based, pH 7.4-8.0)

  • Include appropriate detergents: start with 0.5-1% NP-40 or Triton X-100

  • Add protease inhibitors (PMSF, aprotinin, leupeptin) and phosphatase inhibitors (sodium fluoride, sodium orthovanadate) to preserve post-translational modifications

  • For plant tissues, include polyvinylpyrrolidone (PVP) to remove phenolic compounds

• Antibody coupling strategies:

  • Direct approach: Incubate antibody with lysate, then capture with Protein A/G beads

  • Pre-coupling approach: First bind antibody to beads, then incubate with lysate

  • Covalent coupling: Cross-link antibody to beads to prevent co-elution with target proteins

• Controls and validation:

  • Negative control: IgG from the same species as Os06g0699400 antibody

  • Input control: Sample of lysate before immunoprecipitation

  • Knockout/knockdown control: Lysate from plants with reduced OsMPK4 expression

• Elution conditions:

  • Gentle elution: Competition with excess immunizing peptide

  • Standard elution: Low pH glycine buffer (pH 2.5-3.0)

  • Denaturing elution: SDS sample buffer at 95°C (disrupts all interactions)

• Verification approaches:

  • Western blot with a second anti-OsMPK4 antibody recognizing a different epitope

  • Mass spectrometry analysis of immunoprecipitated proteins

  • Functional assays to verify activity of the immunoprecipitated protein

Optimization of these parameters should be performed systematically, changing one variable at a time to determine optimal conditions for specific experimental goals .

How does antibody structural optimization influence experimental outcomes when working with plant proteins like Os06g0699400?

The structural characteristics of antibodies significantly impact their performance in plant-based experimental systems. Key considerations include:

• Antibody format selection:

  • Full IgG vs. Fab fragments: While full IgGs provide bivalent binding and higher avidity, Fab fragments offer better tissue penetration

  • Monoclonal vs. polyclonal: Monoclonals provide consistency across experiments but recognize single epitopes; polyclonals offer signal amplification but batch variability

• Energy optimization approaches:

  • Antibodies with optimized energy profiles demonstrate improved binding affinity and specificity

  • Energy optimization techniques include computational approaches that minimize CDR (Complementarity Determining Region) total energy while maximizing binding affinity

  • Reduced total energy correlates with more natural-like antibody structures that exhibit improved performance in complex biological systems

• Antibody modifications for plant systems:

  • Fc modifications: N297A mutation reduces binding to Fc receptors, minimizing non-specific interactions

  • Such modifications can be particularly important when working with plant extracts that contain proteins capable of binding to mammalian antibodies

• Epitope accessibility considerations:

  • Target selection should consider accessibility in native protein conformations

  • Antibodies targeting flexible regions may perform differently in various applications

  • Computational prediction of surface-exposed epitopes can guide more effective antibody development

This structural optimization is especially relevant for plant proteins like Os06g0699400/OsMPK4, where the cellular environment and protein characteristics differ from mammalian systems that are more commonly used in antibody development .

How can researchers distinguish between closely related MAPK family members when using Os06g0699400 antibody?

Distinguishing between closely related MAPK family members presents a significant challenge, especially between OsMPK4 and OsMPK3. Methodological approaches to address this include:

• Epitope mapping and sequence alignment analysis:

  • Perform detailed sequence alignment of the immunogen sequence with related MAPKs

  • Note that PHY4570S antibody's synthetic peptide shows 100% homology with OsMPK3 (Os02g0148100)

  • Design experiments with this cross-reactivity in mind

• Differential expression patterns:

  • Leverage known tissue-specific or condition-specific expression differences between MAPK family members

  • Compare antibody signal patterns with transcript-level data from RNA-seq or qPCR

• Knockout/knockdown validation:

  • Use genetic approaches (CRISPR/Cas9, RNAi) to create lines with reduced expression of specific MAPKs

  • Compare antibody signal in wild-type vs. modified lines

• Multi-antibody approach:

  • Use multiple antibodies targeting different epitopes

  • Employ antibodies specific to unique regions of each MAPK

  • Compare signal patterns across different antibodies

• Immunoprecipitation-mass spectrometry:

  • Perform IP followed by high-resolution mass spectrometry

  • Use peptide-level analysis to definitively identify which MAPK isoforms are present

The combination of these approaches provides greater confidence in distinguishing between OsMPK4 and closely related family members in experimental systems .

What are common sources of non-specific binding when using Os06g0699400 antibody and how can they be mitigated?

Non-specific binding can significantly confound experimental results. Common sources and mitigation strategies include:

Additionally, implementing a systematic troubleshooting approach includes:

• Titrating antibody concentrations to find optimal signal-to-noise ratio

• Extending washing steps (both duration and number) after primary antibody incubation

• Using alternative blocking agents (milk vs. BSA vs. fish gelatin) to identify optimal conditions

• Implementing epitope retrieval methods for fixed tissues

These strategies should be applied systematically, evaluating the impact of each modification on specific signal and background levels .

How can energy optimization approaches improve antibody design for targets like Os06g0699400?

Energy optimization represents an advanced approach to antibody design that can significantly enhance specificity and binding characteristics:

• Principles of antibody energy optimization:

  • Total energy (Etotal) optimization creates more stable antibody structures

  • Binding energy (ΔG) optimization enhances target specificity

  • The combination of low total energy and high binding affinity creates ideal antibody candidates

• Computational approaches:

  • Residue-level decomposed energy preference enables fine-tuning of antibody-antigen interactions

  • Gradient surgery techniques address conflicts between attraction and repulsion energies

  • Pre-trained diffusion models can generate optimized antibody structures with naturalistic energy profiles

• Experimental validation of computationally designed antibodies:

  • Surface plasmon resonance (SPR) measurements of binding kinetics

  • Thermal stability assays to confirm structural integrity

  • Competitive binding assays to assess specificity against related proteins

• Application to plant protein targets:

  • Energy-optimized antibodies show improved performance in complex plant extracts

  • Optimization can be tailored to account for the unique physiochemical environment of plant cells

  • Structure-based design can enhance specificity for distinguishing between closely related plant MAPKs

Researchers working with Os06g0699400 can benefit from these approaches by collaborating with computational antibody design groups or utilizing emerging commercial services that implement energy optimization in custom antibody development .

How can Os06g0699400 antibody facilitate research into MAPK-mediated cross-talk between biotic and abiotic stress responses?

Os06g0699400 antibody enables sophisticated investigations into signaling crosstalk through several methodological approaches:

• Multi-stress experimental designs:

  • Apply combinations of biotic stressors (pathogens, PAMPs) and abiotic stressors (drought, salt, temperature)

  • Track OsMPK4 activation patterns using phospho-specific antibodies alongside total OsMPK4 detection

  • Compare timing and magnitude of activation under single vs. combined stress conditions

• Signalosome characterization:

  • Use Os06g0699400 antibody in proximity-dependent labeling approaches to identify context-specific interaction partners

  • Compare OsMPK4 interactomes under different stress conditions to identify unique and shared signaling components

  • Validate key interactions using reciprocal co-immunoprecipitation and functional studies

• Pathway inhibitor studies:

  • Apply specific inhibitors of stress signaling components (e.g., calcium channel blockers, ROS scavengers)

  • Assess the impact on OsMPK4 activation under different stress combinations

  • Build pathway dependency maps based on inhibitor effects

• Genetic background effects:

  • Compare OsMPK4 activation patterns across rice varieties with different stress tolerance profiles

  • Correlate activation patterns with phenotypic outcomes

  • Identify genetic modifiers of OsMPK4-mediated responses

These approaches can reveal how OsMPK4 integrates multiple stress signals and contributes to prioritization of responses when plants face concurrent challenges from biotic and abiotic stressors .

What emerging technologies might enhance the specificity and applications of antibodies targeting plant signaling proteins like Os06g0699400?

Several emerging technologies show promise for enhancing antibody performance in plant research contexts:

• Single-domain antibodies (nanobodies):

  • Derived from camelid heavy-chain antibodies

  • Smaller size enables better tissue penetration and epitope access

  • Can be genetically encoded for in vivo expression in plant systems

• Aptamer technologies:

  • DNA/RNA-based affinity reagents selected through SELEX

  • Can offer specificity comparable to antibodies with greater stability

  • May reduce cross-reactivity issues in plant systems

• Direct energy optimization in antibody design:

  • Computational methods that specifically optimize CDR energetics

  • Residue-level decomposed energy preferences guide antibody optimization

  • Results in antibodies with energies resembling natural antibodies and improved binding characteristics

• Cryo-EM guided epitope selection:

  • High-resolution structural information enables precise epitope targeting

  • Can identify epitopes that distinguish between closely related MAPKs

  • Enables rational design of antibodies with minimal cross-reactivity

• Plant-optimized recombinant antibody expression:

  • Codon optimization for plant expression systems

  • Plant-specific glycosylation patterns that reduce non-specific interactions

  • Expression as secreted proteins in plant biofactories

These technologies represent the cutting edge of antibody development and hold particular promise for challenging applications in plant science research, where traditional antibody approaches sometimes face limitations due to the unique biochemical environment of plant systems .